Jerusalem Daily Journal
SEE OTHER BRANDS

The latest news from Israel

Jerusalem Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jerusalem Daily Journal.

Press releases published on May 7, 2025

300 Pastors, Rabbis, and Faith Leaders Forge Alliance for Israel Advocacy in the Nation’s Capital

300 Pastors, Rabbis, and Faith Leaders Forge Alliance for Israel Advocacy in the Nation’s Capital

Influential rabbis and pastors met in Washington, D.C. to urge Congress for stronger support for Israel. WASHINGTON, DC, DC, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Influential rabbis and pastors met in Washington, D.C. to urge Congress for …

Live From Gaza: Doctors Fighting to Spare Thousands of Children From Starvation to Issue Plea in International ZOOM Call

Live From Gaza: Doctors Fighting to Spare Thousands of Children From Starvation to Issue Plea in International ZOOM Call

Providers struggling against catastrophic conditions in northern Gaza while witnessing a child dying every 40 minutes are begging: Let the children eat! WASHINGTON (DC), DC, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- In Gaza, the World Food …

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects

PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects

TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced the launch of a strategic pilot program with Econergy Renewable Energy Ltd., a leading European independent power producer (IPP). The project will utilize …

ImmuneWalk Therapeutics Announces $7 Million Seed Financing and Upcoming Presentations of Positive Clinical Results at Upcoming Medical and Industry Conferences

ImmuneWalk Therapeutics Announces $7 Million Seed Financing and Upcoming Presentations of Positive Clinical Results at Upcoming Medical and Industry Conferences

Completed seed financing round of $7 million from an institutional investor and ImmuneWalk’s management team Includes oral presentation of positive safety, pharmacokinetic, and pharmacodynamic data from immunology and inflammation (I…

Introducing the Wix Model Context Protocol (MCP) Server for Seamless AI-Driven Web App Development

Introducing the Wix Model Context Protocol (MCP) Server for Seamless AI-Driven Web App Development

With Wix MCP Server, users can leverage natural language prompts to seamlessly connect Wix’s comprehensive business functionality with their preferred compatible AI-powered tools, enabling them to build custom experiences on top of Wix or manage their Wix- …

 INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been …

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

Teva to Host Innovation & Strategy Day on Thursday, May 29 in New York City

TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will host Innovation …

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved

For an accessible version of this Press Release, please visit www.tevapharm.com On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy; Q1 2025 shows ninth consecutive quarter of revenue growth, excluding revenues …

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025

REHOVOT, Israel, and HOBOKEN, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service